Literature DB >> 17851544

Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis.

John Stingl1, Carlos Caldas.   

Abstract

Human breast cancers are heterogeneous, both in their pathology and in their molecular profiles. This suggests the hypothesis that breast cancers can initiate in different cell types, either breast epithelial stem cells or their progeny (transit amplifying cells or committed differentiated cells). In this respect, breast cancer could be viewed as being similar to haematological malignancies for which an analogous model has been proposed. Drawing such parallels might help to unravel the molecular nature of the initiating events in breast cancer and might have substantial clinical implications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17851544     DOI: 10.1038/nrc2212

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  185 in total

Review 1.  Histological types of breast cancer: how special are they?

Authors:  Britta Weigelt; Felipe C Geyer; Jorge S Reis-Filho
Journal:  Mol Oncol       Date:  2010-04-18       Impact factor: 6.603

Review 2.  Breast cancer stem cell hypothesis: clinical relevance (answering breast cancer clinical features).

Authors:  Nuria Rodríguez Salas; Enrique González González; Carlos Gamallo Amat
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

3.  Selection of brain metastasis-initiating breast cancer cells determined by growth on hard agar.

Authors:  Lixia Guo; Dominic Fan; Fahao Zhang; Janet E Price; Ju-Seog Lee; Dario Marchetti; Isaiah J Fidler; Robert R Langley
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

4.  Prepubertal exposure to cow's milk reduces susceptibility to carcinogen-induced mammary tumorigenesis in rats.

Authors:  Tina S Nielsen; Galam Khan; Jennifer Davis; Karin B Michels; Leena Hilakivi-Clarke
Journal:  Int J Cancer       Date:  2011-01-01       Impact factor: 7.396

5.  High-throughput discovery of rare insertions and deletions in large cohorts.

Authors:  Francesco L M Vallania; Todd E Druley; Enrique Ramos; Jue Wang; Ingrid Borecki; Michael Province; Robi D Mitra
Journal:  Genome Res       Date:  2010-11-01       Impact factor: 9.043

6.  Breast cancer risk from different mammography screening practices.

Authors:  Harmen Bijwaard; Alina Brenner; Fieke Dekkers; Teun van Dillen; Charles E Land; John D Boice
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

Review 7.  The impact of the Cancer Genome Atlas on lung cancer.

Authors:  Jeremy T-H Chang; Yee Ming Lee; R Stephanie Huang
Journal:  Transl Res       Date:  2015-08-10       Impact factor: 7.012

Review 8.  Hedgehog signalling in breast cancer.

Authors:  Maria Kasper; Viljar Jaks; Marie Fiaschi; Rune Toftgård
Journal:  Carcinogenesis       Date:  2009-02-23       Impact factor: 4.944

9.  Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.

Authors:  Özge Saatci; Simone Borgoni; Özge Akbulut; Selvi Durmuş; Umar Raza; Erol Eyüpoğlu; Can Alkan; Aytekin Akyol; Özgür Kütük; Stefan Wiemann; Özgür Şahin
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

10.  Heterogeneity in the expression of receptors in the human breast cancer metastasized to the brain.

Authors:  Prema S Rao; Morgan Labhart; Susan L Mayhew; Seshadri Thirumala; U Subrahmanyeswara Rao
Journal:  Tumour Biol       Date:  2014-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.